Naomichi Okamoto

发表

Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021, Cureus.

Vortioxetine Improved Depressive State In Parkinson’s Disease

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021, Cureus.

A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021, International medical case reports journal.

A Case of a Male Patient with Frontotemporal Dementia with Behavioral and Psychological Symptoms Responding to a Low Dose of Escitalopram

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2020 .

Differences in the Disease Severity and Background Characteristics of Patients with Suicide Attempts Due to Overdose According to the Time of Day.

R. Yoshimura, T. Mayumi, Naomichi Okamoto, 2022, Psychiatria Danubina.

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder

R. Yoshimura, Y. Fujino, Rintaro Fujii, 2021, BJPsych Open.

A Young Japanese Patient with Spinocerebellar Ataxia Type 3 Presenting Depressive State with Cenesthopathy and Delusion: a Case Report

R. Yoshimura, S. Ide, Y. Hashimoto, 2021, The Cerebellum.

Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study

R. Yoshimura, N. Iwata, S. Kakeda, 2022, Neurology international.

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study

R. Yoshimura, Y. Korogi, N. Iwata, 2020, Neuropsychiatric disease and treatment.

Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary study

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021, Therapeutic advances in psychopharmacology.

Comparison of plasma catecholamine metabolites in melancholic and non-melancholic depression

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2022, Psychiatry Research Communications.

Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021, Schizophrenia Research.

Disturbed hippocampal intra-network in first-episode of drug-naïve major depressive disorder

R. Yoshimura, S. Kakeda, Keita Watanabe, 2022, Brain communications.

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021, Cureus.

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms

R. Yoshimura, S. Kakeda, Keita Watanabe, 2023, Frontiers in Psychiatry.

Isolated Adrenocorticotropic Hormone Deficiency Accompanied by Impaired Cognitive Function: A Case Report

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021, Psychiatry Research Case Reports.

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia

R. Yoshimura, Keita Watanabe, Rintaro Fujii, 2021, Frontiers in Psychiatry.

Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major Depression

R. Yoshimura, S. Kakeda, Keita Watanabe, 2022, Frontiers in Human Neuroscience.

The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2023, Biomedicines.

Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021, Frontiers in Psychiatry.

Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorder

R. Yoshimura, S. Kakeda, Keita Watanabe, 2023, Frontiers in Psychiatry.

Ultimatum game in recovered schizophrenia patients: preliminary findings

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2022, The European Journal of Psychiatry.

A male case of frontotemporal lobar degeneration with behavioural and psychiatric symptoms responding to a low dose of escitalopram

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls

R. Yoshimura, S. Kakeda, Keita Watanabe, 2022, Frontiers in Molecular Neuroscience.

Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2020, Case reports in psychiatry.

Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings

R. Yoshimura, N. Ueda, Rintaro Fujii, 2021, Frontiers in Psychiatry.

Risk Factors in Japanese Drug Overdose Patients: Identifying Their Associations With Suicide Risk.

R. Yoshimura, Keita Watanabe, Naomichi Okamoto, 2023, Omega.

Increased Stimulation Intensity Helped to Cope with Prolonged Seizures During the Next Round of Modified Electroconvulsive Therapy: A Case Report

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2022, International medical case reports journal.

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2022, Therapeutic advances in psychopharmacology.

A case of exploding head syndrome preceding the onset of mild cognitive impairment with Lewy bodies

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2023, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

L-Arginine-Nitric Oxide Pathway and Neural Networks in Major Depression.

R. Yoshimura, Keita Watanabe, Naomichi Okamoto, 2022, Psychiatria Danubina.

Effect of the personality traits of healthy Japanese workers on depressive symptoms and social adaptation, and on the achievement rate of exercise therapy to prevent major depression

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2023, Frontiers in psychology.

Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation

R. Yoshimura, M. Harada, Yuichi Honma, 2022, Neuropsychiatric disease and treatment.

NDT_A_350121 173..186

R. Yoshimura, M. Harada, Yuichi Honma, 2022 .

Vortioxetine improved olfactory reference syndrome in a patient with major depressive disorder: A case report

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2021 .

Estimation of subjective quality of life in schizophrenic patients using speech features

John Noel C. Victorino, R. Yoshimura, Naomichi Okamoto, 2023, Frontiers in Rehabilitation Sciences.

The Molecular Mechanism of Exercise for Treatment of Patients with Major Depression: A Preliminary Report on the Dynamics of Metabolites of Nitric Oxide and Catecholamines.

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2022, Journal of integrative neuroscience.

Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study

S. Horie, Naomichi Okamoto, A. Ikenouchi, 2023, International journal of molecular sciences.

A Case of 10-Year Retrograde Amnesia, Cognitive Dysfunction, and Hippocampal Atrophy After Limbic Encephalitis Associated with Rickettsiosis

R. Yoshimura, S. Ide, Naomichi Okamoto, 2023, Psychiatry Research Case Reports.

Effects of Paroxetine on Plasma Levels of Vascular Endothelial Growth Factor in Patients with Major Depression.

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2022, Psychiatria Danubina.

Effect of risperidone on plasma vascular endothelial growth factor levels in patients with first-episode schizophrenia: A preliminary study

Naomichi Okamoto, A. Ikenouchi, Issei Seki, 2023, Psychiatry Research Communications.

Association between salivary mature brain-derived neurotrophic factor and psychological distress in healthcare workers.

Rintaro Fujii, Naomichi Okamoto, A. Ikenouchi, 2023, Brain and behavior.

Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression

R. Yoshimura, Naomichi Okamoto, A. Ikenouchi, 2020, Clinical Neuropsychopharmacology and Therapeutics.

Effect modification of tumor necrosis factor-α on the kynurenine and serotonin pathways in major depressive disorder on type 2 diabetes mellitus.

Yuichi Honma, Naomichi Okamoto, A. Ikenouchi, 2023, European archives of psychiatry and clinical neuroscience.

Agoraphobia and panic attacks complicated by primary aldosteronism improved by treatment with eplerenone: a case report

Naomichi Okamoto, H. Tesen, Ryohei Igata, 2023, BMC Psychiatry.